St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
How blinatumomab changed B-ALL therapy and what comes nextÂ
Original lecture date: April 30, 2026
Rachel Rau, MD
Associate Professor, Seattle Children’s Hospital
Register for the lecture series
Other lectures in the Fall 2025 series
- GD2-CART01 for pediatric solid tumors: achievements, challenges and future directions
- Accessing Innovative Medicines for Children and Adolescents with Cancer
- The CHARM of it all: Cell-free DNA sequencing for Hereditary And High-Risk Malignancies
- Developing immune cell therapies for cancer: historical insights, current applications, and pathways to broader impact
- Therapeutic targeting of high-risk leukemia
- Tracing the origins of childhood cancer through genome sequencing
- Backtracking leukemia to its origins
- Exploring the role of somatic mtDNA mutations in acute leukemia
- Leveraging global health priorities to advance scientific discovery
- Predicting and Preventing Late-occurring Adverse Outcomes in Childhood Cancer Survivors
- The neuroscience of childhood brain cancers